322 related articles for article (PubMed ID: 12549928)
1. Cell surface heparan sulfate participates in CXCL1-induced signaling.
Wang D; Sai J; Richmond A
Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
[TBL] [Abstract][Full Text] [Related]
2. PAK1 kinase is required for CXCL1-induced chemotaxis.
Wang D; Sai J; Carter G; Sachpatzidis A; Lolis E; Richmond A
Biochemistry; 2002 Jun; 41(22):7100-7. PubMed ID: 12033944
[TBL] [Abstract][Full Text] [Related]
3. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.
Chandrasekar B; Melby PC; Sarau HM; Raveendran M; Perla RP; Marelli-Berg FM; Dulin NO; Singh IS
J Biol Chem; 2003 Feb; 278(7):4675-86. PubMed ID: 12468547
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
[TBL] [Abstract][Full Text] [Related]
6. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
Merz D; Liu R; Johnson K; Terkeltaub R
J Immunol; 2003 Oct; 171(8):4406-15. PubMed ID: 14530367
[TBL] [Abstract][Full Text] [Related]
7. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
[TBL] [Abstract][Full Text] [Related]
8. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB.
Nilsson G; Mikovits JA; Metcalfe DD; Taub DD
Blood; 1999 May; 93(9):2791-7. PubMed ID: 10216072
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway.
Wang D; Richmond A
J Biol Chem; 2001 Feb; 276(5):3650-9. PubMed ID: 11062239
[TBL] [Abstract][Full Text] [Related]
10. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
Yang W; Schraw WP; Mueller SG; Richmond A
Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
[TBL] [Abstract][Full Text] [Related]
11. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling.
Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A
Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807
[TBL] [Abstract][Full Text] [Related]
12. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
Ahuja SK; Murphy PM
J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
[TBL] [Abstract][Full Text] [Related]
14. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction.
Yang W; Wang D; Richmond A
J Biol Chem; 1999 Apr; 274(16):11328-33. PubMed ID: 10196223
[TBL] [Abstract][Full Text] [Related]
15. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2.
Sanchez X; Suetomi K; Cousins-Hodges B; Horton JK; Navarro J
J Immunol; 1998 Jan; 160(2):906-10. PubMed ID: 9551928
[TBL] [Abstract][Full Text] [Related]
16. Discrete steps in binding and signaling of interleukin-8 with its receptor.
Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide N-oxides as CXCR2 antagonists.
Cutshall NS; Ursino R; Kucera KA; Latham J; Ihle NC
Bioorg Med Chem Lett; 2001 Jul; 11(14):1951-4. PubMed ID: 11459668
[TBL] [Abstract][Full Text] [Related]
18. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
Inngjerdingen M; Rolstad B; Ryan JC
J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]